Targeting inhibition of histone lysine demethylase KDM5B ameliorates myocardial ischemia-reperfusion injury by restoring Brinp2 expression
Biochemical Pharmacology · 2026
DOI: 10.1016/j.bcp.2026.118293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Zhun Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center of Translational Medicine, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangdong 510080, China. Hauptthemen laut MEDLINE: Jumonji Domain-Containing Histone Demethylases, Myocardial Reperfusion Injury, Retinoblastoma-Binding Protein 2. Die Arbeit nennt 40 Literaturangaben.
Abstract (Originalsprache)
Myocardial ischemia/reperfusion (I/R) injury remains a major clinical challenge with limited effective therapies, largely due to incomplete mechanistic understanding. While reactive oxygen species (ROS) overproduction is a central pathogenic event, direct antioxidant strategies have largely failed clinically. Epigenetic regulation, particularly histone methylation, has emerged as a critical player in cardiac stress responses, yet the role of specific histone demethylases in I/R remains largely unexplored. Here, we identify lysine-specific demethylase 5B (KDM5B), an H3K4me3 demethylase, as a key pathogenic mediator and therapeutic target in myocardial I/R injury. KDM5B is markedly upregulated in hypoxic cardiomyocytes, leading to reduced H3K4me3 levels. Pharmacological inhibition of KDM5B with AS8351, or genetic knockdown of KDM5B, protects cardiomyocytes from hypoxia/reoxygenation-induced (H/R) cell death, oxidative stress, and mitochondrial dysfunction. In mice, post-reperfusion AS8351 administration improves cardiac function and reduces infarct size. Integrative transcriptomic and epigenomic analyses identify Brinp2 as a direct transcriptional target of KDM5B. KDM5B occupies the Brinp2 locus, and its inhibition restores H3K4me3 occupancy and Brinp2 expression. BRINP2 partially localizes to mitochondria, and its overexpression is sufficient to enhance ATP production while suppressing ROS. Conversely, Brinp2 knockdown impairs mitochondrial function and autophagic flux, and largely abolishes AS8351-mediated protection both in vitro and in vivo. Collectively, our findings reveal a KDM5B-H3K4me3-BRINP2 epigenetic axis governing cardiomyocyte survival during I/R stress and identify KDM5B as a promising therapeutic target for ischemic heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Translational Medicine, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangdong 510080, China.
- Joint Postdoctoral Research Station, Medical School of Jiaying University, Zhongshan School of Medicine, Sun Yat-sen University, Guangdong 514031, China.
- Clinical Laboratory Medical Center, Shenzhen Hospital, Southern Medical University, Xinhu Road 13, Baoan District, Shenzhen 518110, Guangdong, China.
- College of Bioscience and Bioenginering, Jiangxi Agricultural University, Nanchang 330045, China.
- Department of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen 518110, China.
- Department of Plastic and Hand Surgery, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich 81675 Munich, Germany; Faculty of Medicine, Ludwig-Maximilians University Munich, Munich, Germany.
Zitieren
APA
Liu, Z., Huang, L., Zhang, G., Wang, Z., Nie, Y., Zeng, F., & Zhao, Q. (2026). Targeting inhibition of histone lysine demethylase KDM5B ameliorates myocardial ischemia-reperfusion injury by restoring Brinp2 expression. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118293
Vancouver
Liu Z, Huang L, Zhang G, Wang Z, Nie Y, Zeng F, et al. Targeting inhibition of histone lysine demethylase KDM5B ameliorates myocardial ischemia-reperfusion injury by restoring Brinp2 expression. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118293
BibTeX
@article{Liu2026,
author = {Liu, Zhun and Huang, Liying and Zhang, Guili and Wang, Zixu and Nie, Yage and Zeng, Fanzhu and Zhao, Qingquan},
title = {Targeting inhibition of histone lysine demethylase KDM5B ameliorates myocardial ischemia-reperfusion injury by restoring Brinp2 expression},
journal = {Biochemical Pharmacology},
year = {2026},
doi = {10.1016/j.bcp.2026.118293}
}
EUVIMED